"Chemotherapy, Adjuvant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
| Descriptor ID |
D017024
|
| MeSH Number(s) |
E02.186.170 E02.319.170
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Chemotherapy, Adjuvant".
Below are MeSH descriptors whose meaning is more specific than "Chemotherapy, Adjuvant".
This graph shows the total number of publications written about "Chemotherapy, Adjuvant" by people in this website by year, and whether "Chemotherapy, Adjuvant" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 4 | 4 |
| 1994 | 0 | 3 | 3 |
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 10 | 10 |
| 1997 | 0 | 8 | 8 |
| 1998 | 0 | 3 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 4 | 4 |
| 2001 | 4 | 9 | 13 |
| 2002 | 2 | 3 | 5 |
| 2003 | 0 | 8 | 8 |
| 2004 | 2 | 9 | 11 |
| 2005 | 0 | 11 | 11 |
| 2006 | 0 | 9 | 9 |
| 2007 | 0 | 14 | 14 |
| 2008 | 2 | 17 | 19 |
| 2009 | 0 | 16 | 16 |
| 2010 | 0 | 17 | 17 |
| 2011 | 0 | 19 | 19 |
| 2012 | 0 | 13 | 13 |
| 2013 | 0 | 11 | 11 |
| 2014 | 5 | 5 | 10 |
| 2015 | 1 | 12 | 13 |
| 2016 | 1 | 14 | 15 |
| 2017 | 3 | 15 | 18 |
| 2018 | 0 | 18 | 18 |
| 2019 | 7 | 14 | 21 |
| 2020 | 2 | 4 | 6 |
| 2021 | 2 | 4 | 6 |
| 2022 | 1 | 9 | 10 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemotherapy, Adjuvant" by people in Profiles.
-
Preoperative Treatment of Locally Advanced Rectal Cancer. N Engl J Med. 2023 Jul 27; 389(4):322-334.
-
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials. J Clin Oncol. 2023 03 01; 41(7):1376-1382.
-
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT. J Clin Oncol. 2023 03 01; 41(7):1370-1375.
-
Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial. J Clin Oncol. 2023 01 10; 41(2):316-326.
-
Oncologic end points and implication of trial design in the era of immunotherapy for resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 06; 165(6):1949-1953.
-
A population-based evaluation of tunica vaginalis mesothelioma: An analysis of the National Cancer Database. Urol Oncol. 2023 01; 41(1):52.e11-52.e20.
-
Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study. Gynecol Oncol. 2022 Dec; 167(3):452-457.
-
Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon. Ann Thorac Surg. 2023 06; 115(6):1544-1555.
-
Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance). Oncologist. 2022 06 08; 27(6):e494-e505.
-
Potential evidence of peritoneal recurrence in Stage-II colon cancer from the control arm of CALGB9581. Am J Surg. 2022 07; 224(1 Pt B):459-464.